Biological Psychiatry: A Practice in Search of a Science
The rise of the biological causation model in the past thirty years is traced to psychiatry’s efforts to regain lost status and to protect itself from intrusions by non-medical practitioners, as well as to the pharmaceutical industry’s drive for profits. Evidence in support of the model, including studies of identical twins and of brain structure and function, are less revealing than was earlier thought, due to problems in methodology and interpretation. Organized psychiatry, when challenged in 2003, was unable to provide compelling evidence for biological causation of most mental and behavioral disorders. A paradigm shift away from biological causation and toward environmental causation is called for.
Keywordsbiological causation pharmaceutical industry organized psychiatry efficacy of psychotropic medications identical twins brain imaging paradigm
Unable to display preview. Download preview PDF.
- Andreasen, N. C. (Ed.). (2003). American Journal of Psychiatry, 161.Google Scholar
- Andreasen, N. C. & Black, D. W. (Eds.). (2001). Introductory textbook of psychiatry (3rd ed.). Washington DC: American Psychiatric Press.Google Scholar
- APA deplores Louisiana Governor’s decision to sign psychologist-prescribing bill. (May 6, 2004). News release, American Psychiatric Association, Washington DC.Google Scholar
- Barchas, J. D. (Ed.). (2004). Archives of General Psychiatry, 61.Google Scholar
- Barnett, A.. ( 2003, December 12). Revealed: how drug firms ‘hoodwink medical journals. The Observer/UK News. Retrieved December 10, 2003, from https://doi.org/observer.guardian.co.uk/uk_news/story/0,6903,1101680.00.html.
- Bradshaw, J. (2004, November/December). 8 schools offer full RxP programs. The National Psychologist, 13, 20.Google Scholar
- Bursten, B. (1981). Rallying ‘round the medical model. Hospital and Community Psychiatry, 32, 371.Google Scholar
- Buie, J. (1990, January). President signs Medicare bill: Victory caps uphill trek. APA Monitor, pp. 17–18.Google Scholar
- Clausen, J. A. (1975). The social meaning of differential physical and sexual maturation. In S. E. Dragastin & G. H. Elder (Eds.), Adolescence in the life cycle: Psychological change and the social context (pp. 25–47.). New York: Halstead.Google Scholar
- Coleman, T. (2004, November 20). Serzone drug maker OKs deal. Charleston Sunday Gazette-Mail, p. 3A.Google Scholar
- Comer, R. (2005). Fundamentals of abnormal psychology (4th ed.). New York: Worth.Google Scholar
- Farber, S. L. (1981). Identical twins reared apart. New York: Basic Books.Google Scholar
- Ferrell, G. (2004, May 14). Pfizer settles fraud case for $430 million. USA Today, p. 5D.Google Scholar
- Friedman, H. (2004, November/December). ‘Mad pride’ about prescription privileges. The National Psychologist, 13, 13, 21.Google Scholar
- Friedman, R. A. (2002, August 27). Like drugs, talk therapy can change brain chemistry. New York Times. Retrieved August 1, 2005 from https://doi.org/sfhelp.org/01/cx_us_drugs.htm.
- Glenmullen, J. (2002). Prozac backlash: Overcoming the dangers of Prozac, Zoloft, Paxil and other antidepressants with safe, effective alternatives. New York: Simon & Schuster.Google Scholar
- Graber, J. A., Lewinsohn, P. M., Seeley, J. R. & Grooks-Gunn, J. (1997). Is psychopathology associated with the timing of pubertal development? Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1768–1776. https://doi.org/10.1097/00004583-199712000-00026
- Hales, R. E. & Yudofsky, S. C. (Eds.). (2003). The American psychiatric textbook of clinical psychiatry (4th ed.). Washington DC: American Psychiatric Press.Google Scholar
- Hubbard, R. & Wald, E. (1997). Exploding the gene myth: How genetic information is produced and manipulated by scientists, physicians, employers, insurance companies, educators, and law enforcers (Rev. ed.). New York: Beacon Press.Google Scholar
- Ismail, M. A. Prescription for power: Drug makers’ lobbying army ensures their legislative dominance. Retrieved July 6, 2005, from https://doi.org/publicintegrity.org/lobby/printerfriendly.aspx?aid=685.
- Johnson, L. A. (2004, May 17)). Spending soars for children’s attention deficit, behavior drugs. Charleston Gazette, p. 2D.Google Scholar
- Kahn, A., Leventhal, R., Kahn, S. & Brown, W. (2002). Severity of depression and response to antidepressants and placebo: An analysis of the Food and Drug Administration database. Journal of Clinical Psychopharmacology, 22, 1, 40–45. https://doi.org/10.1097/00004714-200202000-00007
- Kirsch, I., Moore, T. J. & Scoboria, A. (2002). The emperor’s new drugs: An analysis of antidepressant medication data submitted to the U. S. Food and Drug Administration. Prevention & Treatment, 5, Article 23. Retrieved July 26, 2004, from journals.apa.org/prevention/volume5/toc-jul15-02.html.Google Scholar
- Kravitz, R. L. Epstein, R. M. Feldman, M. D., Franz, C. E., Azari, R., Wilks, M. S., Hinton, L. & Franks, P. (2005). Influence of patients’ requests for direct-to-consumer advertised antidepressants. Journal of the American Medical Association, 293, 1995–2002. https://doi.org/10.1001/jama.293.16.1995CrossRefGoogle Scholar
- Lewinton, R. C. (1991). Biology as ideology: The doctrine of DNA. New York: HarperCollins.Google Scholar
- Lewinton, R. C. Rose, S. & Kamin, L. J. (1984). Not in our genes: Biology, ideology and human nature. New York: Pantheon.Google Scholar
- Lucey, J. E. (Ed.). (2003) Pediatrics, 112.Google Scholar
- Midkiff, D. & Wyatt, W. J. (2005, May). A hard look at the “biological causation” rhetoric: The Marshall Project, one year later. Poster presented at the Association for Behavior Analysis, Chicago, IL.Google Scholar
- Mind Freedom (2003, July 28, August 12, 22, September 26). Fast for freedom in mental health. Retrieved December 22, 2003, from https://doi.org/www.mindfreedom.org/mindfreedom/hungerstrike1.stml.
- Nelson, B. (1982, November 2). Psychiatry’s anxious years: decline in allure; as a career leads to self-examination. New York Times, p. C1.Google Scholar
- Owen, M. J. & O’Donovan, M. C. (2002). Schizophrenia and genetics. In R. Plomin, J. C. DeFries, I. W. Craig & P. McGuffin (Eds.), Behavioral genetics in the postgenomic era (pp. 463–489). Washington DC: American Psychological Association.Google Scholar
- Pincus, H. A., Tanielian, T. L., Marcus, S. C., Olfson, M., Zarin, D. A. & Thompson, J. (1998). Prescribing trends in psychotropic medications: Primary care, psychiatry, and other medical specialties. Journal of the American Medical Association, 279, 526–531. https://doi.org/10.1001/jama.279.7.526CrossRefGoogle Scholar
- Psychiatry names task force to stop more psychologists RxP. (2005, January/February). The National Psychologist, 14, 1,3.Google Scholar
- Rubin, R. (2004, October 12). How did Vioxx debacle happen? USA Today, p. 1D,2D.Google Scholar
- Rubin, R. (2005, March 3). “Too cozy’ with drugmakers? USA Today, p. 9D.Google Scholar
- Sagar, A. & Socolar, D. (2001). Drug industry marketing staff soars while research staffing stagnates. Report. Boston University School of Public Health, December 2001.Google Scholar
- Sarason, I. G. & Sarason, B. R. (2002). Abnormal psychology: The problem of maladaptive behavior (10th ed.). New York: Prentice-Hall.Google Scholar
- Schiller, L. & Bennett, A. (1996). The quiet room: A journey out of the torment of madness. New York: Warner Books.Google Scholar
- Skinner, B. F. (1974). About behaviorism. New York: Alfred A. Knopf.Google Scholar
- Small, G. (2003). The memory bible: An innovative strategy for keeping your brain young. New York: Hyperion.Google Scholar
- Tresniowski, A., Rozsa, L. & Brass, K. (2002, October 7). Finding daylight: NFL star Ricky Williams breaks free of the anxiety disorder that nearly ruined his life. People, p. 103.Google Scholar
- Uttal, W. R. (2001). The new phrenology: The limits of localizing cognitive processes in the bbrain. Cambridge, MA: The MIT Press.Google Scholar
- Vaczek, D. (April, 2003). Top 200 drugs for 2002. Pharmacy Times. Retrieved July 26, 2003, from https://doi.org/www.pharmacytimes.com/article.cfm?ID=338.
- Valenstein, E. S. (1998). Blaming the brain: The truth about drugs and mental health. New York: The Free Press.Google Scholar
- Watson, P. (1981). Twins: An uncanny relationship? New York: Viking.Google Scholar
- Wong, S. E. (2005, May). Biomedicalization of social problems: New conquests of the pharmaceutical industry and implications for behavior analysis. Paper presented at the Association for Behavior Analysis, Chicago, IL.Google Scholar
- Wyatt, W. J. (2003, May). Biological causation in the professional and popular cultures: Tactics for dealing with an oversold model. Paper presented at the Association for Behavior Analysis, San Francisco, CA.Google Scholar
- Young, A. & Adams, C. (2003, November 2). ‘I hate what they did.’ Prescribing drugs off-label is routine, but the practice can kill patients. Charleston Gazette-Mail, p. 1A.Google Scholar